The present invention pertains to novel diagnostic assays for the diagnosis of amyloidosis, in particular Alzheimer's disease, and related aspects. In particular, monoclonal antibodies and an antibody assay are provided.
Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides